Hospital
The Blue Hill Memorial Hospital
The Blue Hill Memorial Hospital was paid $1.11M by Medicaid between Jan 2018 and Dec 2024, across 180 billing codes. Its largest line is 99285, emergency room visit (most serious) — 15% of everything it billed.
33Billing provider infoTHE BLUE HILL MEMORIAL HOSPITAL
BLUE HILL, ME 04614
BLUE HILL, ME 04614
33aNPI1023057809assigned 06/06/2006
33bProvider typeCritical Access Hospital
28Total paid$1.11M
24GClaims252,404
24DCodes billed180
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Critical Access Hospital providers in Maine
Rank by total paid#10 of 14
Median peer was paid$1.76M
This provider vs. median0.6×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 30,421 | $172K | |
| 2019 | 31,176 | $145K | |
| 2020 | 31,697 | $139K | |
| 2021 | 50,603 | $167K | |
| 2022 | 47,286 | $186K | |
| 2023 | 39,834 | $162K | |
| 2024incomplete | 21,387 | $135K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 15% | 2,591 | 2,205 | $170K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 14% | 34,163 | 15,870 | $154K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 7.2% | 611 | 564 | $80K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 6.9% | 3,125 | 2,713 | $77K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 6.6% | 30,070 | 12,780 | $73K |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 5.8% | 5,221 | 4,516 | $64K |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | 4.4% | 7,306 | 3,695 | $49K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 4.4% | 3,945 | 3,381 | $49K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 3.9% | 1,756 | 1,189 | $43K |
| 70450 | Computed tomography, head or brain; without contrast material | 3.3% | 460 | 415 | $36K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 3.0% | 6,418 | 2,420 | $34K |
| 80053 | Comprehensive metabolic panel | 2.5% | 10,839 | 9,295 | $28K |
168 more codes
| 96375 | Therapeutic injection; each additional sequential IV push | 1.4% | 1,724 | $16K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | 1.4% | 3,299 | $16K |
| 71046 | Radiologic examination, chest; 2 views | 1.4% | 1,028 | $16K |
| 90837 | Psychotherapy session, about an hour | 1.4% | 4,847 | $16K |
| 71045 | Radiologic examination, chest; single view | 1.3% | 936 | $14K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 1.3% | 2,419 | $14K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 1.2% | 1,278 | $14K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 1.1% | 1,875 | $12K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 10,348 | $8K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 4,575 | $7K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 3,761 | $7K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 2,784 | $6K |
| Q3014 | Telehealth originating site facility fee | <1% | 5,338 | $6K |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 928 | $5K |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 1,223 | $4K |
| 97162 | <1% | 421 | $4K | |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 496 | $4K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 31 | $4K |
| 36415 | Collection of venous blood by venipuncture | <1% | 13,147 | $4K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 708 | $3K |
| 98929 | <1% | 597 | $3K | |
| 82607 | <1% | 1,010 | $3K | |
| 84484 | <1% | 1,709 | $3K | |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 290 | $3K |
| 83735 | <1% | 3,541 | $3K | |
| G0378 | Hospital observation service, per hour | <1% | 17 | $3K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 1,427 | $3K |
| 90832 | Psychotherapy session, about 30 minutes | <1% | 1,522 | $2K |
| 80061 | Lipid panel | <1% | 3,084 | $2K |
| 97161 | <1% | 291 | $2K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 909 | $2K |
| 81001 | <1% | 2,193 | $2K | |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 22 | $2K |
| G0108 | Diabetes outpatient self-management training services, individual, per 30 minutes | <1% | 433 | $2K |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 3,645 | $1K |
| 85027 | <1% | 2,266 | $1K | |
| 82728 | <1% | 829 | $1K | |
| 80306 | <1% | 1,852 | $1K | |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 1,284 | $1K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 1,661 | $1K |
| 86140 | <1% | 1,059 | $1K | |
| 85610 | <1% | 2,234 | $1K | |
| 85652 | <1% | 1,022 | $1K | |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | <1% | 347 | $1K |
| 99350 | Prolong home eval add 15m | <1% | 52 | $989.83 |
| 83540 | <1% | 808 | $876.80 | |
| 90834 | Psychotherapy session, about 45 minutes | <1% | 962 | $868.37 |
| 83880 | <1% | 181 | $864.68 | |
| 97035 | <1% | 261 | $846.27 | |
| 82043 | <1% | 369 | $819.51 | |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | <1% | 1,457 | $805.91 |
| 83690 | <1% | 1,414 | $780.63 | |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | <1% | 4,241 | $754.63 |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 3,937 | $727.24 |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 620 | $702.76 |
| 90715 | <1% | 444 | $700.65 | |
| 83550 | <1% | 637 | $682.13 | |
| 99443 | <1% | 44 | $548.13 | |
| 87631 | <1% | 628 | $544.96 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 763 | $537.02 |
| G0008 | Administration of influenza virus vaccine | <1% | 1,244 | $521.89 |
| 84439 | <1% | 343 | $520.34 | |
| 86618 | <1% | 528 | $515.03 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 918 | $498.25 |
| 73610 | <1% | 27 | $493.47 | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 294 | $483.05 |
| 94760 | <1% | 427 | $431.23 | |
| 82570 | <1% | 241 | $421.63 | |
| 81003 | <1% | 1,280 | $419.15 | |
| 87077 | <1% | 604 | $412.43 | |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | <1% | 3,092 | $362.80 |
| 90662 | <1% | 417 | $342.94 | |
| 96127 | <1% | 291 | $329.50 | |
| 99442 | <1% | 36 | $313.06 | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 123 | $226.71 |
| 91320 | <1% | 173 | $225.74 | |
| 98927 | <1% | 26 | $214.52 | |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 22 | $203.20 |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 3,842 | $188.03 |
| 81002 | <1% | 387 | $182.21 | |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 186 | $162.45 |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | <1% | 32 | $147.17 |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 1,497 | $131.01 |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 741 | $128.45 |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 69 | $109.59 |
| 87468 | <1% | 109 | $109.45 | |
| 0011A | <1% | 779 | $106.00 | |
| 0124A | <1% | 277 | $100.75 | |
| 87186 | <1% | 69 | $98.93 | |
| 0012A | <1% | 883 | $96.79 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 228 | $92.60 |
| 87469 | <1% | 109 | $90.12 | |
| 87484 | <1% | 109 | $90.12 | |
| 90686 | <1% | 1,366 | $87.06 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 795 | $74.83 |
| 98928 | <1% | 30 | $72.25 | |
| 0064A | <1% | 463 | $66.56 | |
| 90480 | <1% | 222 | $58.99 | |
| G0279 | Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | <1% | 14 | $56.91 |
| 87478 | <1% | 67 | $53.91 | |
| G2012 | Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion | <1% | 24 | $52.18 |
| 81025 | <1% | 792 | $49.71 | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 708 | $48.08 |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 625 | $47.84 |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 708 | $46.68 |
| 82948 | <1% | 46 | $38.18 | |
| 99406 | <1% | 73 | $34.74 | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 280 | $34.05 |
| A9270 | Non-covered item or service | <1% | 33 | $33.26 |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 53 | $32.73 |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 1,308 | $30.11 |
| 90670 | <1% | 40 | $18.71 | |
| 86038 | <1% | 12 | $18.26 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 33 | $16.99 |
| 83605 | <1% | 103 | $16.51 | |
| J2704 | Injection, propofol, 10 mg | <1% | 15 | $16.04 |
| 0054A | <1% | 26 | $13.62 | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 19 | $13.61 |
| 85379 | <1% | 15 | $13.54 | |
| 0003A | <1% | 54 | $10.53 | |
| 82565 | <1% | 14 | $8.46 | |
| 90658 | <1% | 15 | $7.61 | |
| 85014 | <1% | 34 | $7.48 | |
| 81015 | <1% | 17 | $7.14 | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 12 | $3.94 |
| 87040 | <1% | 13 | $2.44 | |
| 87205 | <1% | 13 | $0.22 | |
| 82947 | <1% | 14 | $0.14 | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | 0% | 985 | $0.00 |
| 90734 | 0% | 36 | $0.00 | |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 0% | 777 | $0.00 |
| 0002A | 0% | 116 | $0.00 | |
| 90685 | 0% | 331 | $0.00 | |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 0% | 648 | $0.00 |
| 91312 | 0% | 209 | $0.00 | |
| 90713 | 0% | 42 | $0.00 | |
| 90707 | 0% | 27 | $0.00 | |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 0% | 524 | $0.00 |
| 91300 | 0% | 744 | $0.00 | |
| Q2038 | Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluzone) | 0% | 124 | $0.00 |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 0% | 222 | $0.00 |
| 90633 | 0% | 25 | $0.00 | |
| 91322 | 0% | 44 | $0.00 | |
| 80076 | 0% | 13 | $0.00 | |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | 0% | 13 | $0.00 |
| 0004A | 0% | 175 | $0.00 | |
| 0071A | 0% | 82 | $0.00 | |
| 90710 | 0% | 12 | $0.00 | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 0% | 72 | $0.00 |
| 0013A | 0% | 12 | $0.00 | |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | 0% | 27 | $0.00 |
| G8979 | Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting | 0% | 13 | $0.00 |
| 0001A | 0% | 153 | $0.00 | |
| 87081 | 0% | 273 | $0.00 | |
| 91307 | 0% | 68 | $0.00 | |
| G0472 | Hepatitis c antibody screening, for individual at high risk and other covered indication(s) | 0% | 15 | $0.00 |
| 85651 | 0% | 14 | $0.00 | |
| 91305 | 0% | 103 | $0.00 | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | 0% | 27 | $0.00 |
| 91301 | 0% | 1,015 | $0.00 | |
| 91306 | 0% | 63 | $0.00 | |
| 0072A | 0% | 93 | $0.00 | |
| 0154A | 0% | 12 | $0.00 | |
| 0031A | 0% | 32 | $0.00 | |
| 90716 | 0% | 26 | $0.00 | |
| 90656 | 0% | 13 | $0.00 | |
| 90619 | 0% | 19 | $0.00 | |
| 91315 | 0% | 13 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialMERCHANT, WENDY (VP, FINANCE)